As prostate cancer is a biologically heterogeneous disease for which a variety of treatment options are available, the major objective of prostate cancer imaging is to achieve more precise disease characterization. In...As prostate cancer is a biologically heterogeneous disease for which a variety of treatment options are available, the major objective of prostate cancer imaging is to achieve more precise disease characterization. In clinical practice, magnetic resonance imaging （MRI） is one of the imaging tools for the evaluation of prostate cancer, the fusion of MRI or dynamic contrast-enhanced MRI （DCE-MRI） with magnetic resonance spectroscopic imaging （MRSI） is improving the evaluation of cancer locafon, size, and extent, while providing an indication of tumor aggressiveness. This review summarizes the role of MRI in the application of prostate cancer and describes molecular MRI techniques （including MRSI and DCE-MRI） for aiding prostate cancer management.展开更多
A dynamic model of schistosoma japonicum transmission is presented that incorporates effects of the prepatent periods of the different stages of schistosoma into Baxbour＇s model. The model consists of four delay diff...A dynamic model of schistosoma japonicum transmission is presented that incorporates effects of the prepatent periods of the different stages of schistosoma into Baxbour＇s model. The model consists of four delay differential equations. Stability of the disease free equilibrium and the existence of an endemic equilibrium for this model are stated in terms of a key threshold parameter. The study of dynamics for the model shows that the endemic equilibrium is globally stable in an open region if it exists and there is no delays, and for some nonzero delays the endemic equilibrium undergoes Hopf bifurcation and a periodic orbit emerges. Some numerical results are provided to support the theoretic results in this paper. These results suggest that prepatent periods in infection affect the prevalence of schistosomiasis, and it is an effective strategy on schistosomiasis control to lengthen in prepatent period on infected definitive hosts by drug treatment （or lengthen in prepatent period on infected intermediate snails by lower water temperature）.展开更多
文摘As prostate cancer is a biologically heterogeneous disease for which a variety of treatment options are available, the major objective of prostate cancer imaging is to achieve more precise disease characterization. In clinical practice, magnetic resonance imaging （MRI） is one of the imaging tools for the evaluation of prostate cancer, the fusion of MRI or dynamic contrast-enhanced MRI （DCE-MRI） with magnetic resonance spectroscopic imaging （MRSI） is improving the evaluation of cancer locafon, size, and extent, while providing an indication of tumor aggressiveness. This review summarizes the role of MRI in the application of prostate cancer and describes molecular MRI techniques （including MRSI and DCE-MRI） for aiding prostate cancer management.
基金supported by the National Natural Science Foundation of China(Nos.10831003,10925102)the Program of Shanghai Subject Chief Scientist(No.10XD1406200)
文摘A dynamic model of schistosoma japonicum transmission is presented that incorporates effects of the prepatent periods of the different stages of schistosoma into Baxbour＇s model. The model consists of four delay differential equations. Stability of the disease free equilibrium and the existence of an endemic equilibrium for this model are stated in terms of a key threshold parameter. The study of dynamics for the model shows that the endemic equilibrium is globally stable in an open region if it exists and there is no delays, and for some nonzero delays the endemic equilibrium undergoes Hopf bifurcation and a periodic orbit emerges. Some numerical results are provided to support the theoretic results in this paper. These results suggest that prepatent periods in infection affect the prevalence of schistosomiasis, and it is an effective strategy on schistosomiasis control to lengthen in prepatent period on infected definitive hosts by drug treatment （or lengthen in prepatent period on infected intermediate snails by lower water temperature）.
